Abellion
E1468334
UNEXPLORED
Abellion is a Celtic deity, likely associated with the sun or light, venerated in the region of ancient Aquitania.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Abellion canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T21132314 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Abellion Context triple: [Abellio (Celtic deity), nameVariant, Abellion]
-
A.
Kymab
Kymab is a biotechnology company based in Cambridge, UK, focused on developing antibody-based therapeutics using its proprietary transgenic mouse platforms.
-
B.
Alecensa
Alecensa is a targeted cancer therapy (alectinib) primarily used to treat ALK-positive non-small cell lung cancer.
-
C.
Ambrx
Ambrx is a biotechnology company specializing in engineered biologics and next-generation antibody-drug conjugates using expanded genetic code technology.
-
D.
Inflectra
Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
E.
Sygnaq
Sygnaq was a historic Central Asian city that served as an important political and trade center, notably functioning as the capital of the Kazakh Khanate.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Abellion Target entity description: Abellion is a Celtic deity, likely associated with the sun or light, venerated in the region of ancient Aquitania.
-
A.
Kymab
Kymab is a biotechnology company based in Cambridge, UK, focused on developing antibody-based therapeutics using its proprietary transgenic mouse platforms.
-
B.
Alecensa
Alecensa is a targeted cancer therapy (alectinib) primarily used to treat ALK-positive non-small cell lung cancer.
-
C.
Ambrx
Ambrx is a biotechnology company specializing in engineered biologics and next-generation antibody-drug conjugates using expanded genetic code technology.
-
D.
Inflectra
Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
E.
Sygnaq
Sygnaq was a historic Central Asian city that served as an important political and trade center, notably functioning as the capital of the Kazakh Khanate.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.